company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: free trade: Berlin, München, Hamburg, ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, ...
issuer: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: http://www.epigenomics.com sector: Biotechnology ISIN: DE000A1K0516 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, ...
issuer: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: www.epigenomics.com sector: Biotechnology ISIN: DE000A0BVT96, DE000A0XFWF2 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: www.epigenomics.com sector: Biotechnology ISIN: DE000A0BVT96, DE000A0XFWF2 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: www.epigenomics.com sector: Biotechnology ISIN: DE000A0BVT96, DE000A0XFWF2 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: ...
issuer: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: www.epigenomics.com sector: Biotechnology ISIN: DE000A0BVT96, DE000A0XFWF2 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: ...
company: Epigenomics AG Kleine Präsidentenstraße 1 D-10178 Berlin phone: +49 30 24345-0 FAX: +49 30 24345-555 mail: ir@epigenomics.com WWW: www.epigenomics.com sector: Biotechnology ISIN: DE000A0BVT96, DE000A0XFWF2 indexes: Prime All Share, Technology All Share stockmarkets: regulated dealing/prime standard: ...
Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 achim.plum@epigenomics.com Branche: Biotechnology ISIN: DE000A0BVT96 WKN: A0BVT9 Index: Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Stuttgart / free trade Düsseldorf / free trade München / free trade ...
Health economic analysis in favor of Septin9 testing presented by renowned Stanford University researcher at Digestive Disease Week 2011 Patient behavior study underway to demonstrate compliance benefit Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 ...
Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 achim.plum@epigenomics.com Branche: Biotechnology ISIN: DE000A0BVT96 WKN: A0BVT9 Index: Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade ...
Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 achim.plum@epigenomics.com Branche: Biotechnology ISIN: DE000A0BVT96 WKN: A0BVT9 Index: Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade Stuttgart / free trade Düsseldorf / free trade München ...
Continuing to build European market and expanding beyond. Focus 2010/2011 on U.S. product development and FDA submission. Launch of Epi proColon® 2.0 in Europe planned for 2011 Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 achim.plum@epigenomics.com Branche: Biotechnology ISIN: DE000A0BVT96 WKN: A0BVT9 Index: ...
Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 achim.plum@epigenomics.com Branche: Biotechnology ISIN: DE000A0BVT96 WKN: A0BVT9 Index: Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free trade ...
QIAGEN acquires options to mSEPT9 biomarker and DNA methylation technologies; QIAGEN granted license to pursue Septin9 product related R&D Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 achim.plum@epigenomics.com Branche: Biotechnology ISIN: DE000A0BVT96 WKN: A0BVT9 Index: Prime All Share, Technology All Share Börsen: ...
- Strong feasibility study data for improved product concept with 91% sensitivity and 87% specificity - FDA sets February date for Pre-IDE meeting Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. New Products/Molecular diagnostics Subtitle: - Strong feasibility study data for improved ...
Brings significant U.S. experience and strategic transactions expertise Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Personnel/Molecular diagnostics Subtitle: Brings significant U.S. experience and strategic transactions expertise Berlin, Germany, and Seattle, WA, USA, January ...
Current CFO Oliver Schacht leaving by March 31, 2011; Experienced CFO Successor to join April 1st, 2011 Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Personnel/Molecular diagnostics Subtitle: Current CFO Oliver Schacht leaving by March 31, 2011; Experienced CFO Successor to join ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information/Molecular diagnostics Berlin, Germany, and Laval, QC, Canada, December 6, 2010 (euro adhoc) - Epigenomics AG (Frankfurt Prime Standard: ECX), a cancer molecular ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information/Molecular diagnostics Berlin and Seattle, November 23, 2010 (euro adhoc) - Epigenomics AG, the cancer diagnostics company, today announced that they have initiated an observational clinical study for the Epi proColon ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Licensing Agreements/Company Information/Molecular diagnostics BERLIN, PHILADELPHIA, PA and LEXINGTON, MA, November 16, 2010 (euro adhoc) - Epigenomics AG (Frankfurt Prime Standard: ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information/9-month report/Molecular diagnostics Berlin, Germany, November 9, 2010 (euro adhoc) - Epigenomics AG (Frankfurt Prime Standard: ECX) reports today its third quarter and nine months financials for the period ended September 30, 2010. Key Financials | | ...
Third distribution agreement for Epi proColon completes the picture for the Middle East Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information/Molecular diagnostics Subtitle: Third distribution agreement for Epi proColon completes the picture for the Middle East BERLIN ...
Second distributor to be signed-up for Epi proColon - more expected to come shortly Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information/Molecular diagnostics Subtitle: Second distributor to be signed-up for Epi proColon - more expected to come shortly BERLIN and ...